Guangxi Wuzhou Zhongheng Group Co Ltd

600252
stockHealthcarePharmaceuticals
$6/day into 600252 since 2015 would be worth $12,041 today — 0.7× the money.
Try your own number →

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and other healthcare applications. It also provides clindamycin hydrochloride injection, esomeprazole sodium injection, esomeprazole magnesium enteric-coated capsules, cefoperazone dry suspension, naloxone hydrochloride injection, and fludarabine phosphate injection. Further, the company is involved in production of oral care, clothing care, and home care products, including toothpaste; health food business; pharmaceutical distribution; project investment and management; real estate development and operation; and cosmetic products businesses. Guangxi Wuzhou Zhongheng Group Co., Ltd was founded in 1993 and is based in Wuzhou, China.

Description from Yahoo Finance
Full profile on Yahoo Finance →

If you'd bought from year…

Same habit, different start year. Each row shows what a constant habit's worth of 600252-SS would be worth today, had you started buying at that point in the asset's history.

Started$6/day$6/day coffee$42/wk$42/week coffee
Year 1 (2000) — listing
$73,316
1.9×
$104,861
1.9×
Year 6 (2005)
$47,373
1.5×
$68,479
1.5×
Year 11 (2010)
$16,585
0.7×
$24,458
0.7×
Year 16 (2015)
$12,041
0.7×
$17,729
0.7×
Year 21 (2020)
$7,595
0.8×
$11,210
0.8×
Year 26 (2025)
$1,744
0.9×
$2,602
0.9×

Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.

Popular scenarios with 600252

For illustration only — not investment advice. Past performance is not indicative of future results.